Upon completion of this activity, participants should be able to summarize best practices in controversial aspects of hemophilia A care and Identify the current, evolving, and future roles for plasma-derived FVIII.
After completing this activity, the participant should be better able to summarize best practices in controversial aspects of hemophilia A and apply strategies to prevent and eradicate inhibitors in patients receiving FVIII.
The leading cause of non-relapse post- allogeneic hematopoietic stem cell transplant mortality is GvHD manifesting as immunobiological warfare waged by the donor cells against multiple organ systems in the recipient
This interactive monograph will provide the knowledge and skills necessary to make the most appropriate treatment choices for patients, based on patient preferences and lifestyle and interpatient variability in pharmacokinetics.
This three part series is comprised of case-based enduring activities will cover the diagnosis, treatment, and management of patients with cancer who are treated or eligible for treatment with immunotherapy.